# Oncology

## Cancer Statistics

### Leading Cancer Cases

1. Breast
2. Prostate
3. Lung
4. Colorectal
5. Melanoma

### Leading Cancer Deaths

1. Lung
2. Colorectal
3. Pancreas
4. Breast
5. Prostate

## Oncogenes

|Gene|Products|Tumors|
|-|-|-|
|ABL1|Tyrosine kinase|CML|
|BCL2|Anti-apoptotics|Follicular lymphoma|
|BRAF|Serine/Threonine kinase (STK)|Melanoma|
|EGFR<br>HER1<br>ERBB1|Tyrosine kinase|Non-small cell lung cancer (NSCLC)<br>Colorectal cancer|
|NEU<br>HER2<br>ERBB2|Tyrosine kinase|Breast cancer|
|C-KIT|Tyrosine kinase|Gastrointestinal stromal tumor (GIST)|
|C-MYC|Transcription factor|Burkitt lymphoma|
|L-MYC|Transcription factor|Small cell lung cancer (SCLC)|
|N-MYC|Transcription factor|Neuroblastoma|
|KRAS|GTPase|Lung cancer<br>Colorectal cancer<br>Pancreatic cancer|
|RET|Tyrosine kinase|MEN 2A & 2B|

## Tumor Suppressor Genes

|Gene|Products|Tumors|
|-|-|-|
|APC|-|Familial adenomatous polyposis (FAP)|
|ATM|DNA repair|Ataxia telangiectasia|
|BRCA|DNA repair|Breast cancer<br>Ovarian cancer|
|ERCC|DNA repair|Xeroderma pigmentosum|
|FANC|DNA repair|Fanconi anemia|
|MEN1|-|MEN 1|
|MLH1 & MSH2|DNA repair|Lynch syndrome|
|NF1 & NF2|RAS activators|Neurofibromatosis type 1 & 2|
|P16|CDK inhibitors|Melanoma|
|P53|Transcription factor for P21|Li-Fraumeni syndrome|
|PTEN|-|Breast cancer<br>Prostate cancer<br>Endometrial cancer|
|RB|E2F inhibitors|Retinoblastoma<br>Osteosarcoma|
|TSC1 & TSC2|Hamartin<br>Tuberlin|Tuberous sclerosis|
|VHL|HIF inhibitors|Von Hippel-Lindau (VHL) disease|
|WT1 & WT2|-|Wilms tumor<br>WAGR syndrome|

## Tumor Markers

|Marker|Tumors|
|-|-|
|ALP|Bone metastasis<br>Seminoma|
|AFP|Hepatocellular carcinoma<br>Germ cell tumors (GCT)|
|hCG|Hydatidiform moles<br>Germ cell tumors (GCT)|
|CA 15-3|Breast cancer|
|CA 19-9|Pancreatic adenocarcinoma|
|CA 125|Ovarian cancer|
|Calcitonin|Medullary thyroid carcinoma|
|CEA|Colorectal cancer<br>Pancreatic adenocarcinoma|
|Chromogranin|Neuroendocrine tumors (NET)|
|PSA|Prostate cancer|
|S-100|Melanoma<br>Schwannoma<br>Neurofibroma<br>Histiocytoma|

## Common Metastases to Bone

- Breat
- Prostate
- Lung
- Kidney
- Thyroid

## Presentation of Neurofibromatosis Type 1

- Bone dysplasia
- Cafe-au-lait spots
- Lisch nodules
- Neurofibroma
- Optic glioma
- Pheochromocytoma

## Presentation of Neurofibromatosis Type 2

- Acoustic schwannomas :: bilateral
- Cataract
- Meningioma
- Ependymoma

## Presentation of Tuberous Sclerosis {HAMARTOMAS}

- Hamartoma
- Angiofibroma
- Mitral regurgitation
- Ash-leaf spot
- Rhabdomyoma :: heart
- Tubers :: cortex
- Autosomal dominant
- Mental retardation
- Angiomyolipoma :: kidney
- Seizure
- Shagreen patch

## Presentation of Sturge-Weber Syndrome {STURGE-L}

- Sporadic
- Stain :: nevus flammeus
- Tram-track calcification
- Unilateral
- Retardation
- GNAQ gene
- Glaucoma
- Epilepsy
- Episcleral hemangioma
- Leptomeningeal angiomatosis

## Presentation of von Hippel-Lindau (VHL) Disease {HARP}

- Hemangioblastoma
- Angiomatosis
- Renal cell carcinoma (RCC)
- Pheochromocytoma

## WAGR Syndrome {WAGR}

- Wilms tumor [Nephroblastoma]
- Aniridia
- Genitourinary anomaly
- Retardation

## Gardner Syndrome

- Familial adenomatous polyposis (FAP)
- Osteomas
- Soft tissue tumors
- Congenital hypertrophy of retinal pigment epithelium (RPE)
- Impacted / Supernumerary teeth

## Turcot Syndrome

- Colorectal cancer
  - Familial adenomatous polyposis (FAP)
  - Lynch syndrome
- CNS tumors
  - Medulloblastoma
  - Glioma

## Lynch Syndrome

- Hereditary nonpolyposis colorectal cancer (HNPCC)
- Endometrial cancer

## Li-Fraumeni Syndrome & SBLA Syndrome {SBLA}

- Sarcoma
- Breast cancer
- Leukemia
- Adrenal tumor

## Immunotherapy

|Mechanism|Medication|Indications|
|-|-|-|
|Anti-CTLA-4|Ipilimumab|Cancer|
|Anti-PD-1|Nivolumab|Cancer|
||Pembrolizumab|Cancer|
|Anti-PD-L1|Atezolizumab|Cancer|
||Avelumab|Cancer|
||Durvalumab|Cancer|

## Side Effects of Antineoplastics

|Side Effect|Antibiotics|
|-|-|
|Marrow suppression|-|
|Immunosuppression|-|
|Nephrotoxicity|Platinums|
|Neurotoxicity|Nitrosoureas<br>Platinums<br>Vincas<br>Taxanes|
|Cardiotoxicity|Anthracyclines<br>Trastuzumab|
|Pulmonary fibrosis|Bleomycin<br>Busulfan|
|Hemorrhagic cystitis|Cyclophosphamide|
